Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study

Marco Ruella, Andrea Riccardo Filippi, Riccardo Bruna, A. Di Russo, M. Magni, D. Caracciolo, R. Passera, P. Matteucci, M. Di Nicola, P. Corradini, Guido Parvis, G. Gini, A. Olivieri, Marco Ladetto, Umberto Ricardi, C. Tarella, L. Devizzi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study'. Together they form a unique fingerprint.

Medicine & Life Sciences

Physics & Astronomy